ALKS vs MDXG: fair value comparison
Alkermes plc and MiMedx Group, Inc. · Updated 2026-10-19
Both currently screen as overvalued on TickrTrends' Forward Fair Value model. Within Healthcare, ALKS currently sits closer to the top of our ranking by discount to fair value.
| ALKS | MDXG | |
|---|---|---|
| Verdict | Overvalued | Overvalued |
| Last price | $41.22 | $4.43 |
| 12-month range | $27.20–$55.22 | $3.08–$7.96 |
| Rank by discount to fair value | #91 of 108 Healthcare | #93 of 108 Healthcare |
| Quality grade | B | B |
| Leverage | Moderate | Low |
| Margin trend | Stable | Contracting |
| Revenue growth | Strong | Declining |
| RSI zone | Neutral | Neutral |
| 50/200-day trend | Mixed | Downtrend |
| DCF cross-check | Overvalued | Overvalued |
| 52-week position | The upper-middle quarter | The lower-middle quarter |
Full single-stock breakdowns: ALKS fair value analysis · MDXG fair value analysis